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ANTIMICROBIAL DRUGS are commonly used for animals raised 
in food production for treatment, 
control, and prevention of disease as 
well as growth promotion or increased 
feed efficiency in many production 
systems. A recent report from the 
USDA Economic Research Service 
(Sneeringer et al. 2015) indicates that 
the share of hogs, broilers, and beef 
cattle that have been raised without 
the use of antibiotics has increased, 
although a significant share of animals 
do receive antibiotics for growth 
promotion or disease prevention 
(e.g., 59 percent of finishing hogs in 
2009 and 52 percent of broilers in 
2011). Furthermore, many producers 
reported that they did not know about 
their use of antibiotics, particularly 
those producing under contract 
(based on data from the USDA 
Agricultural Resource Management 
Survey, Sneeringer et al. 2015). The 
advantages of using antimicrobials 
in production include prevention of 
mortality and morbidity especially for 
young animals (e.g., weaning pigs), 
reduced input costs (improved feed 
efficiency), and reduced variation in 
growth and final product. However, 
concerns have been raised that the 
extent of antibiotic use in animal 
production has the potential 
to promote the development of 
antibiotic-resistant pathogens that can 
affect human health through exposure 
in food and the environment and limit 
the important and critical benefits of 
drugs used to treat and protect human 
health. Consumer groups and public 
health proponents have pushed for the 
food animal production industry to 
restrict antimicrobial use. 
US Policies and Practices
In 2013, the Food and Drug 
Administration (FDA) issued guidance 
on the appropriate use of “medically 
important” antibiotics in food animal 
production. Guidance #213 includes 
requests to remove use for growth 
promotion through re-labeling 
products to remove feed efϐiciency 
and growth promotion use claims; 
limit application of dosing to speciϐic 
duration and level for an identiϐied 
disease and targeted animal industry; 
avoid administering doses to entire 
ϐlock or herd; and clarify the use of 
drugs for disease prevention. FDA 
also proposed a rule to require the 
use of veterinary feed directives that 
increase veterinary oversight for the 
use of antibiotics deemed medically 
important for human health. USDA 
was directed to “advance development 
and use of antibiotic stewardship 
practices that assure judicious use of 
antibiotics in agriculture.” Alternative 
strategies to preventing and controlling 
disease include vaccination, improved 
animal housing and management 
systems, and adjustments in feeding 
systems. However, changing practices 
and decisions made at the production 
level is challenging, and current data 
systems do not effectively monitor 
usage and applications. 
Concurrent with changes in use 
of antibiotics, efforts are underway to 
improve the reporting on antimicrobials 
sold or distributed for use in food-
producing animals. At the same time, 
the food industry and meat companies 
have responded to consumer demand to 
limit antimicrobial use by adopting new 
requirements on production practices 
and use of antibiotics by suppliers of 
their animal and meat products. For 
example, Perdue Farms has stopped 
almost all antibiotic use in raising 
chicken, Tyson is offering a brand of 
chicken raised without antibiotics, retail 
grocers and food service companies like 
Chick-ϐil-A, Chipotle, and Subway have 
made statements to indicate restriction 
on products (poultry) produced with 
antibiotics, and other stores like Wal-
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Mart are offering beef, pork, and chicken 
raised without antibiotics as a specialty 
product. In response, producers and 
animal practitioners have expressed 
concerns that restricting use in the 
treatment of disease risks harm to 
animal welfare. The policy for animals 
in the United States is still evolving 
and differs from policy enacted in the 
European Union where there is less use 
of voluntary efforts, and greater use of 
restriction on producer and veterinary 
practice. Many of the differences 
between the United States and 
European Union stem from differences 
in the data systems used to track drugs 
used in veterinary practice. 
The Danish Experience
Denmark was one of the earliest 
countries to adopt more restrictive 
policies on the use of antibiotics and, 
as a major producer of pork in the 
world market, can offer lessons on the 
practice and effectiveness of policies 
and restrictions on their antimicrobials 
in animal production. Denmark 
prohibited the use of antimicrobials 
for growth promotion in 1998 and 
restricted use in all production 
phases in 2000. Hayes and Jensen 
(2003) conducted one of the early 
studies to assess implications of such 
restrictions on the US swine industry. 
Based on parameters from the Danish 
experience, they applied biological 
and economic modeling to the US 
production systems and concluded that 
the ban at the weaning stage was the 
most difϐicult—minimizing the effects 
of reducing usage requires changes in 
management and production practices 
and coordination between producer 
and veterinary services, especially for 
young pigs. 
In Denmark, further reductions in 
antimicrobial use have resulted from 
tighter controls on veterinary practices, 
monitoring veterinary prescriptions, 
the use of a “yellow card” system to 
ϐlag producers and operations with 
high use (implemented in 2010), and 
limiting the ability of veterinarians 
to proϐit from sales. Denmark 
maintains an extensive antimicrobial 
monitoring and research program with 
collaborating ofϐices in veterinary, 
food, and health institutes and agencies 
and an integrated data reporting 
system through veterinary practices, 
private laboratories, processing plants, 
and health services and hospitals. 
Antimicrobial use in animal production 
is monitored by speciϐic drug, quantity, 
veterinarian, specie, animal age group, 
and farm identiϐication. However, 
close examination of the current 
Danish system shows that challenges 
in on-farm and veterinary practices 
to increasingly tighter controls 
remain (Jensen and Hayes 2014). 
Most recently, Denmark implemented 
additional taxes on veterinary sales 
including a differentiated tax on 
antibiotics (highest on the most 
critically important antibiotics) 
and removed the existing tax on 
vaccines, which may reduce the 
need for antibiotics. Despite the 
overall decrease in consumption of 
antimicrobial agents in Denmark, the 
overall effectiveness of reduced animal 
use in mitigating development of 
antimicrobial resistance is mixed. 
Implications for the United States
Although the Danish context is 
signiϐicantly different than that in the 
United States, the Danish experience 
offers insight into the implications from 
a shift in US policy and food industry 
practice to implement more restrictions 
on antibiotic use in animal production. 
Experience with the most efϐicient and 
best managed production facilities 
indicates that production systems can 
operate well without compromising 
productivity, although with some 
increase in costs. New research is 
improving our understanding of 
the development and persistence 
of resistance at the farm and in the 
human population. Understanding the 
management and production practices 
in a multi-disciplinary context is 
necessary to reduce resistance and 
exposures in the environment and 
on-going work and collaborations at 
Iowa State University are currently 
addressing these problems. 
In addition to farm-level practices, 
there are adjustments likely to occur 
throughout the supply chain that will 
favor producers with the ability to 
have tighter production controls and 
meet the requirements of buyers with 
stricter standards on antimicrobial use. 
Global trade and production systems 
pose other challenges. Recent problems 
of E. coli resistant to cephalosporins 
in poultry in Denmark were traced to 
grandparent ϐlocks in Great Britain. 
If there are cost increases at the 
production level, consumers are likely 
to bear some of the cost of adjustment 
through higher prices. However, based 
on industry response and observation 
of the development and persistence of 
market niches offering products with 
limited use of antibiotics, consumers 
do have a choice and some are willing 
to pay the price. Companies in the food 
service industry trying to guarantee 
product sourced with more restrictive 
practices now need to compete for more 
limited supply of product raised with 
limited use of antimicrobials. From 
the public health perspective, there is 
a critical need to determine if efforts 
in animal and food sectors will have a 
positive effect on reducing the overall 
level of exposure to antimicrobial 
resistance in human health. 
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